Disc Medicine, Inc.
NASDAQ:IRON · NASDAQ Global Market
-$0.02 today
Vol 1.25M · Avg 0.47M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $88.9M |
| Short-term Investments | $641.2M |
| Other Current | $17.3M |
| Total Current Assets | $747.5M |
| PP&E (Net) | $2.0M |
| Other Non-current | $721.0K |
| Total Non-current Assets | $2.8M |
| Total Assets | $750.2M |
Analysis
Selected assets total $750.2M for Latest. The largest visible component is Short-term Investments at $641.2M, about 85.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91.1M -52.6% | $192.4M -46.6% | $360.4M +85.2% | $194.6M +121.1% | $88.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $700.0M +135.3% | $297.4M | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $0 | $0 | $0 | $0 | $0 | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $12.7M +241.3% | $3.7M | $0 | $0 +100.0% | -$802.0K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $803.9M +62.9% | $493.6M +35.0% | $365.7M +84.2% | $198.5M +119.4% | $90.5M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $2.3M -2.8% | $2.3M +10.5% | $2.1M +31.4% | $1.6M -8.5% | $1.7M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $726.0K -13.4% | $838.0K +258.1% | $234.0K +101.7% | $116.0K -35.6% | $180.0K | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $3.0M -5.6% | $3.2M +35.3% | $2.3M +36.2% | $1.7M -11.1% | $1.9M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $806.9M +62.4% | $496.8M +35.0% | $368.0M +83.8% | $200.2M +116.6% | $92.4M | $13.3B | $11.9B | $10.6B |
| Account Payables | $9.0M +13.5% | $7.9M -37.1% | $12.6M -21.9% | $16.2M +531.6% | $2.6M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $611.0K | $0 | $0 | $0 -100.0% | $5.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $27.0M +274.6% | $7.2M +24.5% | $5.8M +59.8% | $3.6M +149.9% | $1.4M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $36.6M +57.1% | $23.3M +8.8% | $21.4M -5.0% | $22.6M +68.2% | $13.4M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $1.3M -95.6% | $28.3M | $0 | $0 -100.0% | $404.0K | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $29.2M | $0 | $0 | $0 -100.0% | $141.5M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $30.4M +1.8% | $29.9M +1980.1% | $1.4M +39.8% | $1.0M -99.3% | $143.2M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $67.1M +26.1% | $53.2M +132.5% | $22.9M -3.1% | $23.6M -84.9% | $156.6M | $14.7B | $3.7B | $9.6B |
| Common Stock | $4.0K +33.3% | $3.0K +50.0% | $2.0K +0.0% | $2.0K | $0 | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$510.2M -71.2% | -$298.0M -58.0% | -$188.6M -68.1% | -$112.2M -71.6% | -$65.4M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $965.0K +233.9% | $289.0K | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $739.8M +66.8% | $443.6M +28.5% | $345.1M +95.4% | $176.6M +375.1% | -$64.2M | $9.1B | $7.7B | $3.3B |
| Total Debt | $1.9M -93.8% | $30.0M +1327.9% | $2.1M +57.5% | $1.3M -81.1% | $7.1M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$89.3M +45.0% | -$162.4M +54.7% | -$358.3M -85.4% | -$193.3M -138.7% | -$81.0M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.59B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.45B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.38B
Legend Biotech Corporation
NASDAQ:LEGN
$5.32B
Celcuity Inc.
NASDAQ:CELC
$4.19B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.17B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.78B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.71B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
Ascentage Pharma Group International
NASDAQ:AAPG
$407.64M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does IRON have?
Disc Medicine, Inc. (IRON) reported $91.14M in cash and equivalents in fiscal 2025.
How much debt does IRON carry?
Disc Medicine, Inc. (IRON) reported $1.86M of total debt, with net debt of -$89,281,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.